CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
March 18, 2024 06:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
March 14, 2024 07:30 ET
|
Purple Biotech Ltd.
Contribution of NK cells engager arm and conditionally activated T cell engager demonstrated Cleavable capping technology confines therapeutic activity to the local tumor micro environment which...
iSpecimen Strengthens Global Oncology Biospecimen Offering
December 07, 2023 07:30 ET
|
iSpecimen Inc
LEXINGTON, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for...
AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for the Treatment of Advanced Recurrent Ovarian Cancer
November 08, 2023 08:45 ET
|
AIM ImmunoTech Inc.
Data presented at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting Longitudinal comparison of biomarkers in tumor microenvironment showed a gradual, durable response over...
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award
October 23, 2023 08:12 ET
|
Adlai Nortye Ltd.
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a global clinical-stage biotechnology...
Global Peripheral Blood Mononuclear Cells Research Report 2023-2028: Advancements in Toxicology Research, Rising Significance in Cell Therapy, & Increased Investment in R&D for Human Well-Being
October 04, 2023 10:03 ET
|
Research and Markets
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By...
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
September 27, 2023 09:18 ET
|
Pyxis Oncology
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers,...
The Global Cell Separation Market size is expected to reach $17.5 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period
August 30, 2023 10:59 ET
|
ReportLinker
New York, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cell Separation Market Size, Share & Industry Trends Analysis Report By Product Type, By...
Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
August 14, 2023 16:01 ET
|
Design Therapeutics, Inc.
DT-216 Resulted in a Significant Increase in FXN mRNA Levels in Skeletal Muscle of FA Patients Treatment Generally Well-Tolerated; Injection Site Reactions Attributable to Current Formulation...
Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update
August 10, 2023 16:05 ET
|
Salarius Pharmaceuticals, Inc.
FDA removed partial clinical hold for Ewing sarcoma Phase 1/2 study with seclidemstat SP-3164 targeted protein degrader received Investigational New Drug clearance from FDA Company to explore...